Monday, August 06, 2007

Kerfuffle Erupts Involving Geron, Biopolitical Times

Geron, stem cell scientist Hans Keirstead, New Yorker magazine and – all play a part in a recent piece about failed promises on the Biopolitical Times blog.

Jesse Reynolds of the Center for Genetics and Society has posted a good wrapup of the kerfuffle, in which Kierstead takes on Reynolds and vice versa. It all began last week when Reynolds said that Geron has repeatedly promised the beginning of stem cell trials that have not materialized within the predicted time frame. picked up the Reynolds piece. Kierstead then commented online that had peformed a “tremendous disservice to the stem cell field.”

Reynolds replied in the latest posting:
"The truth is that (Brandon) Keim (of Wired) and I did little more than cite public statements made by Geron's chief executive. Isn't it (Tom) Okarma (president of Geron) who is disserving the stem cell field by misrepresenting the feasibility of Geron's stem cell clinical trials over and over again?"
Reynolds' term for the time periods that have elapsed between predictions of clinical trials? “Okarma units.” Sphere: Related Content

No comments:

Post a Comment